ITIL-306 in Advanced Solid Tumors
Instil Bio
Instil Bio
OncoC4, Inc.
Seagen Inc.
SystImmune Inc.
Numab Therapeutics AG
Lyell Immunopharma, Inc.
Celldex Therapeutics
M.D. Anderson Cancer Center
University of Pennsylvania
Hoffmann-La Roche
ADC Therapeutics S.A.
Celldex Therapeutics
Gilead Sciences
Celldex Therapeutics
Xencor, Inc.
Xencor, Inc.
AstraZeneca
Abramson Cancer Center at Penn Medicine
Celgene
Critical Outcome Technologies Inc.
Santa Maria Biotherapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)